![Rami Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rami Levin
Amministratore Delegato presso
CNS PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 30/06/2026
Profilo
Rami Levin is President, Chief Executive Officer & Director at CNS Pharmaceuticals, Inc. since 2026.
Former positions include President & Chief Executive Officer at Saniona AB from 2020 to 2022, Chief Executive Officer at ImStem Biotechnology, Inc. from 2022 to 2024, Vice President-Marketing at EMD Serono, Inc., Head-North America at Swedish Orphan Biovitrum AB, and President at Swedish Orphan Biovitrum, Inc. Education includes undergraduate studies at Tel-Aviv University and an MBA from Recanati Business School Tel Aviv University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Rami Levin
| Società | Posizione | Inizio |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Amministratore Delegato | 01/01/2026 |
Precedenti posizioni note di Rami Levin
| Società | Posizione | Fine |
|---|---|---|
ImStem Biotechnology, Inc.
 ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology Provides therapeutic and research products | Amministratore Delegato | 01/01/2024 |
| SANA AB | Amministratore Delegato | 30/04/2022 |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Presidente | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Vendite & Marketing | - |
Formazione di Rami Levin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
1
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
ImStem Biotechnology, Inc.
ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology Provides therapeutic and research products | Health Technology |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Recanati Business School Tel Aviv University
 Recanati Business School Tel Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
